Form 4 Tracker
Ultragenyx Pharmaceutical Inc.
RARE

36 insider filings · Latest: Sep 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Sep 15, 2026Sep 15 10:57 PMTheodore Alan HuizengaSVP, Chief Accounting Officer
Sale
1,283$13.57$17.4K67,863(D)

View →

Sep 15, 2026Sep 15 8:33 PMTHEODORE HUIZENGA
Proposed Sale
1,283$13.61$17.5K—

View →

Sep 3, 2026Sep 8 4:29 PMTheodore Alan HuizengaSVP, Chief Accounting Officer
Sale
161$13.99$2.3K69,146(D)

View →

Aug 3, 2026Aug 4 7:15 PMKarah Herdman ParschauerEVP and Chief Legal Officer
Sale
1,900$24.92$47.3K92,562(D)

View →

Aug 3, 2026Aug 4 7:13 PMHoward HornChief Financial Officer
Sale
4,696$24.92$117.0K96,295(D)

View →

Aug 3, 2026Aug 3 8:18 PMHOWARD HORN
Proposed Sale
4,696$24.92$117.0K—

View →

Jul 1, 2026Jul 6 7:37 PMHoward HornChief Financial Officer
Sale
4,698$33.13$155.6K100,991(D)

View →

Jul 1, 2026Jul 1 8:19 PMHOWARD HORN
Proposed Sale
4,698$33.13$155.6K—

View →

Jun 15, 2026Jun 15 10:50 PMCorazon (Corsee) D. SandersDirector
Sale
2,000$25.05$50.1K21,095(D)

View →

Jun 15, 2026Jun 15 10:46 PMKarah Herdman ParschauerEVP and Chief Legal Officer
Sale
1,899$24.62$46.8K94,462(D)

View →

Jun 15, 2026Jun 15 8:50 PMKARAH PARSCHAUER
Proposed Sale
3,799$24.35$92.5K—

View →

Jun 15, 2026Jun 15 8:12 PMCORAZON D. SANDERS
Proposed Sale
2,000$25.05$50.1K—

View →

Jun 1, 2026Jun 1 11:11 PMHoward HornChief Financial Officer
Sale
4,653$23.77$110.6K105,689(D)

View →

Jun 1, 2026Jun 1 8:08 PMHOWARD HORN
Proposed Sale
4,653$23.77$110.6K—

View →

May 18, 2026May 18 10:41 PMShehnaaz SulimanDirector
Sale
5,740$25.12$144.2K27,951(D)

View →

May 18, 2026May 18 8:50 PMSHEHNAAZ SULIMAN
Proposed Sale
5,740$25.12$144.2K—

View →

May 5, 2026May 6 6:51 PMEric CrombezEVP and Chief Medical Officer
Sale
344$24.96$8.6K111,189(D)

View →

May 1, 2026May 4 9:35 PMHoward HornChief Financial Officer
Sale
4,683$24.90$116.6K110,342(D)

View →

May 1, 2026May 1 8:06 PMHOWARD HORN
Proposed Sale
4,683$24.90$116.6K—

View →

Apr 1, 2026Apr 2 10:19 PMHoward HornChief Financial Officer
Sale
4,683$20.97$98.2K80,351(D)

View →

Page 1 of 3

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 14, 2026May 18 10:50 PMMatthew K FustDirector
Grant/Award
14,058$25.8014,058(D)

View →

May 14, 2026May 18 10:41 PMShehnaaz SulimanDirector
Grant/Award
14,058$25.8014,058(D)

View →

May 14, 2026May 18 10:39 PMAmrit RayDirector
Grant/Award
14,058$25.8014,058(D)

View →

May 14, 2026May 18 10:38 PMCorazon (Corsee) D. SandersDirector
Grant/Award
14,058$25.8014,058(D)

View →

May 14, 2026May 18 10:35 PMMichael NarachiDirector
Grant/Award
14,058$25.8014,058(D)

View →

May 14, 2026May 18 10:23 PMDaniel G WelchDirector
Grant/Award
14,058$25.8014,058(D)

View →

May 14, 2026May 18 10:21 PMDeborah DunsireDirector
Grant/Award
14,058$25.8014,058(D)

View →

Apr 22, 2026Apr 24 8:39 PMTheodore Alan HuizengaSVP, Chief Accounting Officer
Grant/Award
7,348$24.617,348(D)

View →

Apr 16, 2026Apr 20 9:19 PMEmil D KakkisDirector, President & CEO
Grant/Award
132,693$24.52132,693(D)

View →

Apr 16, 2026Apr 20 9:17 PMDennis Karl HuangEVP, Chief Technical Operations Officer
Grant/Award
79,936$24.5279,936(D)

View →

Apr 16, 2026Apr 20 9:16 PMJohn Richard PinionEVP, Chief Quality Operations Officer
Grant/Award
79,936$24.5279,936(D)

View →

Apr 16, 2026Apr 20 9:15 PMKarah Herdman ParschauerEVP and Chief Legal Officer
Grant/Award
49,960$24.5249,960(D)

View →

Apr 16, 2026Apr 20 9:13 PMErik HarrisEVP & Chief Commercial Officer
Grant/Award
49,960$24.5249,960(D)

View →

Apr 16, 2026Apr 20 9:11 PMEric CrombezEVP and Chief Medical Officer
Grant/Award
59,952$24.5259,952(D)

View →

Apr 16, 2026Apr 20 9:09 PMHoward HornChief Financial Officer
Grant/Award
59,952$24.5259,952(D)

View →